Presentation AHA 2014 Efficacy and safety of vorapaxar in NSTE ACS patients undergoing non-cardiac surgery Presenter: S. van Diepen November 16, 2014
News Conference News AHA 2014 Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery Yael L. Maxwell November 16, 2014
Presentation Reappraisal of Thienopyridine Pretreatmentin NSTE-ACS Patients Presenter: A. Bellemain-Appaix November 06, 2014
News Daily News New Syntax Tool Gauges Completeness of Revascularization, Predicts Prognosis October 24, 2014
Presentation TCT 2014 Role of Intravascular Imaging in NSTE-ACS and STEMI Presenter: Nils Johnson, Bernhard Witzenbichler, Michel R. Le May, Fernando Alfonso September 16, 2014
Presentation TCT 2014 Role of FFR, IMR, and Other Physiologic Measures in NSTE-ACS and STEMI Presenter: Nils Johnson, Bernhard Witzenbichler, Michel R. Le May, Colin Berry September 16, 2014
Presentation TCT 2014 Preloading P2Y12 Antagonists in NSTE-ACS and STEMI: Safe and Effective? What Regimens? Presenter: Dominick J. Angiolillo September 13, 2014
Presentation TCT 2014 NSTE-ACS: Risk Stratification and Treatment Presenter: Emmanouil S. Brilakis, Dmitriy N. Feldman September 13, 2014
Presentation TCT 2014 Case #1: NSTE-ACS Caused by Neoatherosclerosis in Saphenous Bypass Grafts: Insights from OCT Presenter: Dan Deleanu, Dariusz Dudek, Robert J. Gil, Greg L. Kaluza, Andrzej J. Ochala, Wojtek Wojakowski September 13, 2014
News Daily News European Societies Release Updated Revascularization Guidelines for CAD L.A. McKeown September 11, 2014
News Conference News ESC 2014 RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years Caitlin E. Cox September 03, 2014
News Conference News ESC 2014 ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients Yael L. Maxwell September 03, 2014
News Daily News With Some Caveats, SAFE-PCI Shows Positive Signs for Radial Access in Women Yael L. Maxwell September 02, 2014